Correlation Between Pmv Pharmaceuticals and Kiromic Biopharma
Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and Kiromic Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and Kiromic Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pmv Pharmaceuticals and Kiromic Biopharma, you can compare the effects of market volatilities on Pmv Pharmaceuticals and Kiromic Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of Kiromic Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and Kiromic Biopharma.
Diversification Opportunities for Pmv Pharmaceuticals and Kiromic Biopharma
0.74 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Pmv and Kiromic is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and Kiromic Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kiromic Biopharma and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with Kiromic Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kiromic Biopharma has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and Kiromic Biopharma go up and down completely randomly.
Pair Corralation between Pmv Pharmaceuticals and Kiromic Biopharma
If you would invest 268.00 in Kiromic Biopharma on November 3, 2024 and sell it today you would earn a total of 0.00 from holding Kiromic Biopharma or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 4.76% |
| Values | Daily Returns |
Pmv Pharmaceuticals vs. Kiromic Biopharma
Performance |
| Timeline |
| Pmv Pharmaceuticals |
| Kiromic Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Pmv Pharmaceuticals and Kiromic Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pmv Pharmaceuticals and Kiromic Biopharma
The main advantage of trading using opposite Pmv Pharmaceuticals and Kiromic Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, Kiromic Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kiromic Biopharma will offset losses from the drop in Kiromic Biopharma's long position.| Pmv Pharmaceuticals vs. MediciNova | Pmv Pharmaceuticals vs. Pharvaris BV | Pmv Pharmaceuticals vs. PepGen | Pmv Pharmaceuticals vs. Anebulo Pharmaceuticals |
| Kiromic Biopharma vs. Quoin Pharmaceuticals Ltd | Kiromic Biopharma vs. Allarity Therapeutics | Kiromic Biopharma vs. Virax Biolabs Group | Kiromic Biopharma vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |